Shift Biosciences announces key appointments to advance rejuvenation therapeutics pipeline

FHS
March 12, 2025
10:50 am

Shift Biosciences, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the appointments of Jill Reckless, Ph.D, as Translation Advisor and Laurence Reid, Ph.D., as Non-Executive Director. In these roles, Jill and Laurence will guide Shift in building a robust product translation and business development strategy respectively, enabling the Company to capitalize on early momentum and progress its pipeline of novel rejuvenation therapeutics towards clinical development.

Workplace bullying drives emotional exhaustion and job dissatisfaction among female workers

Workplace bullying against women in Pakistan is driving emotional exhaustion and job dissatisfaction among female workers, new research reveals.

July 17, 2024

Which States Could Have Abortion on the Ballot in 2024?

A ballot measure to scale back the abortion ban in Arkansas won’t go before voters after the secretary of state on Wednesday found that organizers

July 12, 2024

Smartphone-Based Lifestyle Interventions Result in Modest, Sustained Weight Loss

Smartphone-based behavioral interventions for weight loss were more effective when they involved financial incentives or one-on-one coaching calls, two randomized trials showed. In one trial,

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.